Clinical features, outcomes, and costs of a conjunctivitis outbreak caused by the ST448 strain of Streptococcus pneumoniae

Cornea. 2009 Jun;28(5):503-9. doi: 10.1097/ICO.0b013e3181909362.

Abstract

Purpose: An outbreak of pneumococcal conjunctivitis occurred at Dartmouth College in 2002. We describe the clinical features, outcomes, and costs associated with this outbreak.

Methods: Six hundred ninety-eight students were diagnosed with conjunctivitis; culture of conjunctival discharge was obtained for 254. A screening protocol was used to evaluate 67 patients. A retrospective survey was offered to all 698 cases and follow-up clinical examination to all patients with culture-confirmed infection (n = 110). Local ophthalmology offices were contacted to develop a cost analysis. The college health service provided conjunctivitis data for nonoutbreak years.

Results: Of 67 patients evaluated using the screening protocol, findings associated with culture-confirmed Streptococcus pneumoniae conjunctivitis (P < 0.01) were red eye visible from 2 feet, any type of conjunctival discharge, obscuration of tarsal conjunctival blood vessels, and chemosis. Two hundred thirty-two students responded to our retrospective survey; 89% reported bilateral eye involvement; 96% received topical antibiotics and noted symptom improvement within 3 days of treatment. No ocular sequelae were identified as a result of this infection. No recurrent outbreaks have occurred at Dartmouth since the initial event. The estimated cost of this outbreak including evaluations, cultures, and antibiotics ranged from $66,468 to $120,583.

Conclusions: The ST448 strain of S. pneumoniae caused a disruptive outbreak of conjunctivitis at Dartmouth College. A screening protocol was effective at identifying culture-positive cases. Although most culture-positive patients experienced bilateral conjunctivitis, the clinical course was mild with quick resolution of symptoms after initiating antibiotics and no ocular sequelae.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Topical
  • Anti-Bacterial Agents / administration & dosage
  • Conjunctivitis / epidemiology*
  • Conjunctivitis / microbiology*
  • Conjunctivitis / pathology
  • Conjunctivitis / physiopathology
  • Disease Outbreaks / economics*
  • Health Care Costs*
  • Humans
  • Mass Screening
  • Pneumococcal Infections* / diagnosis
  • Pneumococcal Infections* / drug therapy
  • Retrospective Studies
  • Species Specificity
  • Streptococcus pneumoniae / genetics*
  • Treatment Outcome
  • United States / epidemiology
  • Young Adult

Substances

  • Anti-Bacterial Agents